Skip to main content

Table 1 Patients demography and clinical presentation

From: Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer

Characteristics

Values

Age (years)

Median 54 (range 42-74)

Gender (male/female)

19/4 (82.6%/17.4%)

Karnofsky performance score ≥ 70

23 (100%)

Pathology of primary tumor

  ▪ Hepatocellular carcinoma

17 (73.9%)

  ▪ Intrahepatic cholangiocarcinoma

4 (17.4%)

  ▪ N/O

2 (8.7%)

Lesions per patient

  ▪ 1

22 (95.7%)

  ▪ >1

1 (4.3%)

Symptoms

  ▪ Presented

6 (26.1%)

  ▪ None

17 (73.9%)

Location of AGMs

  ▪ Left

4 (17.4%)

  ▪ Right

18 (78.3%)

  ▪ Left and right

1 (4.3%)

Systemic therapy

  ▪ Yes

8 (34.8%)

  ▪ None

15(65.2%)

Metastases in other sites (at the same time)

  ▪ Yes

14 (60.9%)

  ▪ None

9 (39.1%)

SBRT for other sites (at the same time)

  ▪ Yes

10 (43.5%)

  ▪ None

13 (56.5%)

  1. N/O not obtained, AGMs adrenal gland metastases, SBRT stereotactic body radiation therapy